Biote

Biote Payables Turnover

The Payables Turnover Ratio of Biote (BTMD) as of Oct 29, 2026 is 8.04. In the previous year, Payables Turnover Ratio was 10.00 — a change of -19.63% (lower).

Payables Turnover

8.04

YoY

-19.63%

Last updated:

Payables Turnover Ratio of Biote is 2025 8.04 . Payables Turnover Ratio of Biote was 2024 10.00 . It decreases by -19.63% lower compared to the previous year.

The Biote Payables Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Payables Turnover
Date
Payables Turnover
Jan 1, 2019
13.66 USD
Jan 1, 2020
18.38 USD
Jan 1, 2021
11.22 USD
Jan 1, 2022
13.27 USD
Jan 1, 2023
13.93 USD
Jan 1, 2024
10.00 USD
Jan 1, 2025
8.04 USD
The Biote Payables Turnover history
YEARPayables TurnoverYoY
8.04-19.63%
10.00-28.21%
13.93+4.95%
13.27+18.24%
11.22-38.92%
18.38+34.51%
13.66—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biote Stock analysis

What does Biote do? biote Corp. generates revenue through its Biote Method platform, which offers certified practitioners comprehensive tools for hormone optimization. The platform includes education, training, certification, practice management software, inventory management software, and marketing support. Biote also sells a branded line of dietary supplements directly to practitioners and patients. The company's primary customers are Biote-certified practitioners who use the platform to build and manage hormone optimization programs, while the dietary supplements target patients seeking complementary wellness solutions. The Biote Method's proprietary clinical decision support (CDS) system helps physicians personalize patient dosing, enhancing the value proposition for practitioners. By providing end-to-end solutions—from certification to software tools—biote Corp. creates recurring revenue streams through ongoing platform usage and product sales. The company's focus on hormone replacement therapy (HRT) products and practitioner support positions it within the specialized healthcare market segment for bio-identical hormone therapy. biote Corp. differentiates itself through its woman-led structure and comprehensive approach to hormone optimization. The firm's revenue model relies on both service-based offerings for practitioners and direct sales of branded supplements. This dual approach ensures consistent income from certified practitioners who depend on the platform for practice management and from patients purchasing the supplement line as part of their wellness regimen. Biote is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biote stock

Payables Turnover Ratio of Biote is 8.04 in 2025.

Payables Turnover Ratio of Biote changed from 10.00 to 8.04, representing a -19.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Payables Turnover Ratio Biote since 2006 – with annual values, charts, and detailed analysis.

Payables turnover measures how quickly a company pays its suppliers. Lower turnover may indicate better payment terms or cash flow management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Payables Turnover Ratio's Biote with sector peers and the industry average to assess whether it is attractive.

To evaluate Payables Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Payables Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Biote

All Key Metrics — Biote